Clinical Trials Solutions

About Amaros

Amaros is a private, early-stage company founded in 2021, focusing on applying AI and machine learning to ophthalmology data. Its core offering is the AmarosEngine™, a closed-system platform that unifies and analyzes real-world ophthalmic data to generate evidence-based insights. The company targets three primary customer segments: clinical practices (for operational efficiency and patient care), clinical trial sponsors/CROs (for study optimization and enrollment), and life sciences commercial teams (for market strategy). As a platform company, it appears to be in an early-revenue phase, building its network of provider clinics and technology partners.

Therapeutic Areas